ILLUMINA, INC.

ILMN
Delayed Quote. Delayed  - 06/28 04:00:01 pm
187.43USD -3.06%

Turn to zoom
Prev.187.4300
Open194.6600
High196.8144
Low187.3500
Volume1 501 106
Latest news
19h ago
1d ago
5d ago
5d ago
Chart ILLUMINA, INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBearishBearish
Resistance213258304
Spread/Res.-12%-27%-38%
Spread/Supp.3,2%3,2%0,07%
Support182182187
Financials
Sales 2022 5 203 M - -
Net income 2022 449 M - -
Net cash 2022 557 M - -
P/E ratio 2022 64,0x
Yield 2022 -
Capitalization 29 445 M 29 445 M -
EV / Sales 2022 5,55x
EV / Sales 2023 4,62x
Nbr of Employees 9 825
Free-Float 79,4%
Company
Illumina, Inc. specializes in the development, manufacturing and marketing of integrated systems for the analysis of genetic variation and biological function. The group's products are for genomic research centers, pharmaceutical companies, university institutions, clinical research organizations,...
Sector :
Other Advanced Medical Equipment & Technology
Calendar :
2022-08-01 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Last Close Price 187,43 $
Average target price 359,13 $
Spread / Average Target 91,6%